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Baby
crazy

Rolling, crawling, and some already walking, 20 infants
put “Baby Day” in full motion. Accurately guessing the
babies’ ages was the goal of first-year physical therapy
students, using motor development assessments
they’ve learned in Kinesiology (motion science) class.
Clockwise from left, the babies and their proud moms:
Isa with physical therapy instructor Patty McGee, DPT;
Emma with Carolyn Holman, DPT ’06; and Sophie with
physical therapy instructor Stacy Tylka, DPT.
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Early exposure

Gut microbes in healthy kids carry antibiotic-resistance genes

F

riendly microbes in the intestinal
tracts of healthy American children
have numerous antibiotic-resistance
genes, according to a pilot study by School
of Medicine scientists. The genes are cause
for concern because they can be shared with
harmful microbes, interfering with antibiotic
effectiveness in ways that can contribute to
serious illness or death.
“From birth to age 5, children receive
more antibiotics than during any other
five-year time span in their lives,” said senior
author Gautam Dantas, PhD, assistant professor of pathology and immunology. “Frequent
exposure to antibiotics accelerates the spread
of antibiotic resistance. Our research highlights how important it is to only use these
drugs when they are truly needed.”
With funding from the Children’s
Discovery Institute, the International Center
for Advanced Renewable Energy and
Sustainability, the National Academies Keck
2 Washington University School of Medicine

Futures Initiative and the National Institutes
of Health (NIH), the researchers analyzed fecal
samples from 22 infants and children ages
6 months to 19 years. Phillip I. Tarr, MD, the
Melvin E. Carnahan Professor of Pediatrics at
the medical school, provided the samples.
Despite the small sample size, the analysis
identified 2,500 new antibiotic-resistance
genes, expanding the list of known antibioticresistance genes by more than 30 percent.
“Microbes have been battling each other
for millennia, regularly inventing new antibiotic-synthesis genes to kill off rivals and new

“There were quite a
few resistance genes
in microbes from every
child we looked at.”
— G AUTAM DANTA S, PhD

antibiotic-resistance genes to defend themselves,” Dantas said.
The scientists identified the new resistance
genes by testing intestinal microbial DNA from
the children against 18 antibiotics. The identified genes impaired the effectiveness of all
but four of the drugs.
Babies lack microbes in their intestinal
tracts at birth. They establish their communities of gut microbes through ingestion of
microorganisms in their environment — from
crawling on the floor, for example, to putting
toys and other objects into their mouths, to
contact with their primary caregivers.
According to the Centers for Disease
Control and Prevention, antibiotic-resistant
infections cause at least 2 million illnesses
and 23,000 deaths annually, adding $20 billion
in health-care costs. Methicillin-resistant
Staphylococcus aureus now causes more
U.S. deaths than HIV. Scientists use the term
“resistome“ to refer to the collective antibioticresistance genes of a microbial community.
“There were quite a few resistance genes
in microbes from every child we looked at,”
Dantas said. “This was true even in children
who were only 6 months old. When we compared their resistomes to those of older children,
there didn’t seem to be much difference.”
Spring 2014

Babies with leukemia inherit
strong genetic predisposition
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Todd E. Druley, MD, PhD,
studies the genetics
of leukemia.

MIR VISUAL MEDIA CENTER PHOTOS

Babies who develop leukemia during the first year of life
appear to inherit an unfortunate combination of genetic variations that can make the infants highly susceptible to the disease, according to a new study at the School of Medicine and
the University of Minnesota. The research is available online
in the journal Leukemia.
Doctors have long puzzled over why it is that babies just a
few months old sometimes develop cancer. As infants, they
have not lived long enough to accumulate a critical number
of cancer-causing mutations.
The babies appear to have inherited rare genetic variants from
both parents that by themselves would not cause problems,
but in combination put the infants at high risk of leukemia.
These variants most often occurred in genes known to be
linked to leukemia in children, said Todd E. Druley, MD,
PhD, a Washington University pediatric oncologist who
treats patients at St. Louis Children’s Hospital.
Only about 160 infant leukemia cases are diagnosed annually in the U.S. But unlike leukemia in older children, which
often can be cured, about half of infants who develop leukemia die of the disease.
The researchers sequenced all the genes in the DNA of
healthy cells from 23 infants with leukemia and their mothers.
Looking at genes in the healthy cells helped the researchers
understand which genetic variations were passed from a
mother to her child, and by process of elimination, the scientists could determine the father’s contribution to a baby’s DNA.
Among the families studied, there was no history of pediatric cancers. Other children in the families typically don’t
develop leukemia because a roll of the genetic dice likely
means they did not inherit the same combination of harmful
genetic changes, he added.

STEVE DOLAN

ZACH SMYTH/ERIC YOUNG

Both parents carry DNA variations

Blue behemoth

Workers lower a cyclotron into its East
Building vault on the Medical Campus. The unit, in the works for
more than a decade, is a particle accelerator that will produce radioactive compounds, many of which are used with positron emission
tomography (PET) scanners to detect types of cancers. Eventually, the
new cyclotron will replace two others on campus that make these
compounds. The new cyclotron will have higher energy and increased
capacity to produce needed PET drugs.The Cyclotron Facility is part of
Washington University’s Mallinckrodt Institute of Radiology.

Holtzman named AAAS fellow
Michael J. Holtzman, MD, has been named a fellow of the
American Association for the Advancement of Science
(AAAS). The rank of fellow is the highest honor awarded
by AAAS in recognition of distinguished efforts to advance
science or its applications.
Holtzman, the Selma and Herman Seldin
Professor of Medicine, is being honored for
his contributions to understanding and treating chronic lung diseases such as asthma
and chronic obstructive pulmonary disease
and the role of respiratory viruses in these
disorders.
Holtzman has performed pioneering
research on the unsuspected link between
acute viral infection and chronic inflamma- Michael J. Holtzman, MD
tory disease. His recent insight uncovered
the possibility that viral infections may reprogram lung
stem cells as a renewable trigger for chronic inflammation.
In addition to defining the cause of lung disease,
Holtzman has led the development of a drug discovery
program that includes new facilities for high-throughput
screening, medicinal chemistry and structural biology. As
part of the program, scientists are identifying new therapeutics and translating them into practice to reduce excess
mucus production, combat viral infection and inhibit
inflammation in the airway.
A key characteristic of Holtzman’s approach has been the
multidisciplinary nature of his group’s research activities.
Outlook 3
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Diabetes drugs affect the hearts
of men and women differently

Good medicine Rowan Karvas, a research technician in
radiation oncology, and Daniel Kober, a PhD student in microbiology,
play “Sonata for Two Clarinets ” at the third annual winter concert.
Held in the Center for Advanced Medicine lobby, the free concert
showcases Medical Center musicians in a range of genres. The program is designed to connect current and future health-care providers
through music and bring comfort to patients and guests.

Head of ophthalmology named
Todd P. Margolis, MD, PhD, has been named head of the
Department of Ophthalmology and Visual Sciences. With
the appointment, Margolis also becomes ophthalmologistin-chief at Barnes-Jewish Hospital.
Margolis comes from the University
of California, San Francisco (UCSF),
where he was professor of ophthalmology and the Rose B. Williams Chair for
Research in Corneal Diseases.
His clinical expertise is in the
diagnosis and management of infectious
and inflammatory eye disease, with a
particular interest in eye disease due to
herpes viruses and ocular infections in
immune-compromised patients.
Todd P. Margolis, MD, PhD
A 1977 graduate of Stanford
University, Margolis subsequently received a doctorate in
neuroscience and a medical degree from UCSF in 1984.
After an internship in San Francisco, he trained as a resident in ophthalmology at UCSF and later did subspecialty
training in corneal and external diseases at the F.I. Proctor
Foundation. He completed postdoctoral research training
in the Department of Microbiology and Immunology at the
University of California, Los Angeles, where he served as a
visiting assistant professor at the Jules Stein Eye Institute.
Margolis replaces Michael A. Kass, MD, who led the
department since 1999, building it into one of the largest eye
and vision research centers in the U.S. Kass will maintain a
Enjoy interactive elements and added content
clinical practice and continue serving as senior associate
dean for human research protection.
4 Washington University School of Medicine

Widely used treatments for type 2 diabetes have different
effects on the hearts of men and women, even as the drugs
control blood sugar equally well in both sexes, according
to School of Medicine researchers.
In particular, the commonly prescribed diabetes drug
metformin had positive effects on heart function in women
but not in men, who experienced a shift in metabolism
thought to increase the risk of heart failure.
“We saw dramatic sex differences in how the heart
responds to the different therapies,” said senior author
Robert J. Gropler, MD, professor of radiology. The study
appeared in the American Journal of Physiology — Heart
and Circulatory Physiology.
To the researchers’ knowledge, this is the first study to
investigate sex differences in the heart’s response to diabetes
treatments. In type 2 diabetes, the pancreas continues to
make insulin, but the body can’t use it effectively to move
glucose out of the blood and into the tissues. And for reasons
that are not entirely clear, patients with diabetes are at higher
risk for heart failure.
“It is imperative that we gain understanding of diabetes
medications and their impact on the heart to design optimal
treatment regimens for patients,” said Janet B. McGill, MD,
professor of medicine and a study co-author.
The investigators evaluated commonly prescribed diabetes drugs in 78 patients. The research suggests that divergent
responses in men and women may provide at least a partial
explanation for the conflicting data surrounding some diabetes drugs. Specifically, the proportion of men and women
participating in a clinical trial may play an unappreciated
role in whether drugs are deemed safe and effective.

Janet B. McGill, MD,
and Robert J. Gropler,
MD, look through the
PET scanner they and
their colleagues used
to study the heart’s
response to common
diabetes therapies.
They found large
differences in heart
metabolism between
men and women
taking widely used
diabetes drugs.
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Residents honored
with high-flying
breakfast

The Division of Medical Education treated residents
to games, prizes and lots of good food in “Funuary”
to keep them energized and ready to face the final
weeks of winter. Above: Victoria J. Fraser, MD, the
Adolphus Busch Professor of Medicine and chair of the

Department of Medicine, and Melvin S. Blanchard,
MD, division chief and associate professor of medicine, showed off their culinary — and pancakeflipping — skills as they served breakfast to the
hardworking house staff.

GENETIC TESTING

T

he School of Medicine now offers
genetic testing to help diagnose and
treat patients with heart disorders
that can lead to sudden death.
The new test, offered though the school’s
Genomics and Pathology Services (GPS) and
developed in collaboration with Washington
University cardiologists, analyzes genes linked
to arrhythmias and cardiomyopathies.
Physicians who treat patients with indications of these heart conditions can submit a
blood sample for gene sequencing. In two to
three weeks, they receive a report from GPS
describing any mutations identified in the
patient’s DNA that may contribute to disease
and affect response to treatment.
“Results from this test can help us refine
diagnoses and allow us to personalize management and treatment of our patients,” said
Phillip S. Cuculich, MD, assistant professor of
medicine and one of the cardiologists involved
in test development. “The results also may
help family members of affected patients
decide if they want to be tested to see if they
are at risk for developing the disease.”
outlook.wustl.edu

Called the Washington University
CardioGene Set, the test builds on another
first-of-its-kind test offered by GPS that
analyzes multiple genes in tumors. Seeking
genomic clues to personalize cancer diagnosis
and treatment, oncologists nationwide have
been sending tissue samples to GPS for this
test for two years.
“The CardioGene Set is the next major
step in our effort to bring the promise of
human genomics to the clinic,” said Karen
Seibert, PhD, director of GPS. “With rapid and
sensitive gene-sequencing technology, we
check dozens of heart disease genes simultaneously to cost-effectively identify the likely
genetic cause.”
The cardiac testing panel includes genes
linked to eight cardiac disorders that are characterized by irregular heartbeats (arrhythmias)
or heart muscle problems (cardiomyopathies).
For example, the test analyzes the
sequences of genes linked to long-QT syndrome, a rare inherited arrhythmia that lengthens the time between heartbeats, potentially
causing heart palpitations or cardiac arrest.

GPS

Alerting to the risk for sudden death

These genes can help doctors identify particular subtypes of long QT. Different forms of
long QT respond to different therapies, so this
information helps guide treatment decisions.
Patients with hypertrophic cardiomyopathy (HCM), a thickening of the heart muscle
that can lead to sudden cardiac arrest and
other problems, also can benefit from the
CardioGene Set.
HCM is infamous for causing sudden fatal
cardiac arrests in young athletes who never
showed any symptoms of heart problems.
Genetic diagnosis of this condition may lead
physicians to advise a patient against physical
overexertion.
Outlook 5
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Alcohol, tobacco, drug use far
higher in severely mentally ill
Hruz

Shenoy

White

Scholars in pediatrics

The School of Medicine and its
Department of Pediatrics have established funding for three pediatric
scholars named in honor of a trio of highly regarded former pediatricians at the university. The medical school is funding these awards
with $3 million to be divided among the three faculty members, in
support of their time and efforts devoted to scholarship and teaching.
The funding recipients, each of whom practices at St. Louis Children’s
Hospital, are: Paul W. Hruz, MD, PhD, as the Julio V. Santiago, MD,
Scholar in Pediatrics; Shalini Shenoy, MD, as the Teresa J. Vietti, MD,
Scholar in Pediatrics; and Andrew J. White, MD, as the Philip R. Dodge,
MD, Scholar in Pediatrics. The scholars are appointed for three years.

Researchers decode hookworm DNA
Going barefoot in parts of Africa, Asia and South America
contributes to hookworm infections, which afflict an estimated 700 million of the world’s poor. The parasitic worm
lives in the soil and enters the body through the feet. By feeding on victims’ blood, the worms cause anemia and, in children, stunted growth and learning problems.
Now, School of Medicine researchers
have decoded the genome of the
hookworm, Necator americanus,
finding clues to how it infects
and survives in humans and
aiding in the development
An estimated 700 million
of new therapies to combat
people worldwide are infected
hookworm disease.
with hookworms, which feed
“This information will
on blood, causing anemia and,
accelerate development of
in children, stunted growth
new diagnostic tools and vacand learning problems.
cines against the infection,” said
Makedonka Mitreva, PhD, assistant professor of medicine and of genetics and a member of The
Genome Institute at Washington University.
In the U.S. and other industrial countries, hookworms are
gaining attention for their therapeutic potential in the treatment of autoimmune conditions, such as inflammatory bowel
disease, multiple sclerosis, asthma and even allergies.
The scientists discovered that hookworms, to evade detection by the host immune system, appear to suppress molEnjoy interactive elements and added content
ecules that promote inflammation. This same approach may
prove valuable in the treatment of autoimmune conditions.
6 Washington University School of Medicine

Links with shorter life expectancy
In the largest assessment of substance use among people
with severe psychiatric illness, researchers at the School of
Medicine and the University of Southern California have
found that rates of smoking, drinking and drug use are significantly higher among those who have psychotic disorders
than among those in the general population. The study is
published online in the journal JAMA Psychiatry.
The finding is of particular concern because people with
severe mental illness are more likely to die at a younger age.
“These patients tend to pass away much younger, with
estimates ranging from 12 to 25 years earlier than individuals in the general population,” said first author Sarah
M. Hartz, MD, PhD, assistant
professor of psychiatry at
Washington University.
“They don’t die from
drug overdoses or commit suicide — the kinds
of things you might
suspect in severe psychiatric illness. They
die from heart disease
and cancer, problems
caused by chronic alcohol
and tobacco use.”
The study analyzed smoking, drinking and drug use in
A higher incidence of
nearly 20,000 people, includchronic alcohol and
ing 9,142 psychiatric patients
tobacco use causes more
diagnosed with schizodeaths than suicide.
phrenia, bipolar disorder or
schizoaffective disorder.
The investigators also assessed nicotine use, heavy drinking, heavy marijuana use and recreational drug use in more
than 10,000 healthy people without mental illness.
The researchers found that 30 percent of those with
severe psychiatric illness engaged in binge drinking, defined
as drinking four servings of alcohol at one time. The rate of
binge drinking in the general population is 8 percent.
Among those with mental illness, more than 75 percent
were regular smokers, compared with 33 percent of those in
the control group. There were similar findings with heavy
marijuana use: 50 percent of people with psychotic disorders
used marijuana regularly, versus 18 percent in the general
population. Half of those with mental illness also used other
illicit drugs, while the rate of recreational drug use in the
general population is 12 percent.
Spring 2014
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Tread the Med

Back row, from left: Susan George, Sarah Fowler-Dixon, Linda Van Zandt, Jamie Rose, Rick Chandel, Debbie Aumer
and Carla Pinkston. Front row, from left: Nikki Koehnemann, Kerri Morgan and Jacki Epps-Wilbanks.

Tread the Med, the School of Medicine’s popular program that encourages employees to
walk 10,000 steps daily, began Feb. 27 with
an Olympics-themed kickoff on the Medical
Campus. Kerri Morgan, an instructor in occupational therapy and neurology, spoke to
participants about her journey to becoming
a bronze-medal winner in the 2012 London
Paralympic games. The event included a
recap of the most recent Tread the Med and
recognized top achievers. Participants are
given pedometers and challenged to record
progress online — with the ultimate goal
of 500 miles, or 1 million steps, in 100 days.
Tread the Med is sponsored by the School of
Medicine’s Wellness Committee.

OPHTHALMOLOGY RESEARCH

Shining a light on older adults’ vision

O

lder adults who have 20/20 vision
in their eye doctors’ offices may
not see as well at home. School
of Medicine researchers suggests dim lighting
may be the culprit.
Their study is published online in the
journal JAMA Ophthalmology.
“It’s very common for older patients to
have concerns about their vision but then
test well on the eye charts when we examine
them,” said first author Anjali M. Bhorade,
MD, a Washington University ophthalmologist at Barnes-Jewish Hospital. “In this study,
we found that vision in patients’ homes was
significantly worse than in the clinic. The major
factor contributing to this difference was poor
lighting in the home.”
The researchers studied 175 patients ages
55-90. These included 126 with glaucoma.
All patients had their vision measured at home
and at the Glaucoma and Comprehensive
Eye Clinics at the School of Medicine.
The average scores on vision tests were
better in the clinic than at home, Bhorade said.
Nearly 30 percent of the patients with glauoutlook.wustl.edu

coma were able to read at least two or more
extra lines on an eye chart in the clinic than on
the same chart at their homes, and 39 percent
of those with advanced glaucoma read three
or more additional lines in the clinic.
“Older adults with and without glaucoma
had similar differences in vision between the
clinic and home,” said Bhorade, an associate
professor of ophthalmology and visual sciences. “These differences occurred not only
with distance and near vision, but with contrast sensitivity and glare testing, too. The
biggest difference we observed was for distance vision in patients with advanced glaucoma. They had even bigger declines in
vision at home.”
Lighting levels were below the recommended range in more than 85 percent of
the homes visited.
“Since most older adults spend the majority of time at home, our study suggests that
better lighting may increase vision and possibly improve the quality of life for a large
number of people,” Bhorade said.
Although the study didn’t look specifically

at potential dangers associated with low light,
such as falls, other research has determined
that a difference of two or more lines on an
eye chart is associated with a significant difference in how a person functions in daily life.
The findings suggest that a simple solution
may help older adults function at their maximum potential.
“Clinicians should refer their patients for a
customized in-home evaluation by an occupational therapist or low-vision rehabilitation specialist who can make suggestions to optimize
the lighting in people’s homes,” Bhorade said.
Outlook 7
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The proton beam delivers a dose directly to the site of the tumor
and to the correct depth, leaving critical organs untouched.

Cancer destroyer

Powerful innovation; precision therapy

Shown during installation: A superconducting synchrocyclotron proton
accelerator is a key component of the new proton therapy system.
This is the first single-room proton therapy unit in the world. The
$20-million device improves upon traditional systems, which typically are
housed in football field-sized buildings and cost more than $150 million.
outlook.wustl.edu
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R

adiation oncologists at Washington University
School of Medicine have a new option for
treating cancer patients — proton therapy.
The S. Lee Kling Proton Therapy Center, which
opened in January, provides proton therapy to adult
patients of the Alvin J. Siteman Cancer Center at BarnesJewish Hospital and Washington University School of
Medicine and pediatric patients of St. Louis Children’s
Hospital. Patients eligible for the therapy have cancer
near vital structures such as the
spine, brain, heart and eyes.
“Proton therapy is unique
because it allows for very precise
adjustments to the radiation beam,
so we can target tumors,” said
Jeffrey D. Bradley, MD, director of
the proton therapy center. “It helps
to minimize damage to surrounding tissue and is especially useful
when treating growing children.”
Jeffrey D. Bradley, MD, shows
For example, treatment of a
one of the custom-made
brain tumor with proton therapy
apertures that precisely
may be less likely to result in
targets a tumor.
blindness or other complications,
said Bradley, who also is the S. Lee Kling Professor of
Radiation Oncology at Washington University.
The S. Lee Kling Proton Therapy Center plans to treat
20 to 25 patients a day. Treatment typically requires daily
30-minute sessions for two months. The center will serve
the Midwest; the next closest location offering proton
therapy is 225 miles away.
The MEVION S250 Proton Therapy System was
developed and manufactured by Littleton, Mass.-based
Mevion Medical Systems with the assistance of radiation
oncologists and physicists at Washington University.
Outlook 9
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will see you now
Scripted scenarios, intelligent improv
and informed feedback hone the
clinical skills of tomorrow’s physicians
B Y D E B PA R K E R

E D R E G G I H A P P I LY R E P O R T S T H AT,
since 2009, he has suffered from tuberculosis, bouts
of depression, stomach ulcers, acid reflux, diabetes,
sleep apnea, migraines, night sweats, chest pains and
high blood pressure. He looks forward to developing
many more ailments in the coming years.
Committed to helping medical students
become better doctors, he is one of nearly 70 local
professional actors working as standardized patients
(SPs) at Washington University School of Medicine.
They portray real patients, and repeatedly subject
themselves to physical exam by inexperienced hands.
In this safe practice environment, medical students
hone their clinical skills.
Through this immersive program that builds in
complexity over four years, students undergo a
stunning transformation. Here, they learn to get
comfortable touching and examining patients, taking
histories, asking personal questions and writing
will have practiced delivering a terminal diagnosis.

10 Washington University School of Medicine

ROBERT BOSTON

notes. By the program’s conclusion, the students

A high-tech space in the Farrell Learning
and Teaching Center is dedicated solely to
SP instruction. Thirteen simulated clinical
exam rooms and two hospital rooms
surround a central instruction area. The
rooms, in effect, are stages equipped with
recording devices. Instructors follow the
action on a control panel. Right: Dehra
A. Glueck, MD, medical director of the
Standardized Patient Program, with Alan I.
Glass, MD, clinical skills section leader.

Spring 2013
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Furniture, equipment, lighting
— each “classroom” simulates
a real-world clinical setting.
Students gain experience and
confidence through feedback from
faculty instructors as well as the
standardized patients. A camera,
left, records the interactions for
in-depth evaluation.

As the process unfolds, students learn more about
who they are as individuals and how they can better connect with their future patients. In a benefit
not afforded in the real world, SPs are trained to
critique the students’ techniques — breaking character after a simulation and telling them exactly
what it felt like to be their patient.
Program organizers say, in the real world, most
people “vote with their feet”: If displeased with
a doctor’s lack of attentiveness or communication, they simply won’t come back or won’t follow
health recommendations.

T H E ST U DE N T M UST
suspend disbelief, read the
door note, knock and enter.



A standardized patient,
already in character, awaits.

“Patients today tell us, ‘I want you to be a good
diagnostician and practice evidence-based medicine, but that’s not sufficient. I also want you to
be able to talk to me,’” said Dehra A. Glueck, MD,
assistant professor of psychiatry and medical director of the Standardized Patient Program. Glueck
also served on a communications skills task force
for the National Board of Medical Examiners.
The initial, one-on-one standardized patient
encounter happens early in the first year. The stu12 Washington University School of Medicine

dent must suspend disbelief, read the door note,
knock and enter. A standardized patient, already
in character, awaits.
The challenge: ask the right questions, keep the
patient on topic, gather information, respond to
concerns and be empathic.
“This is about being fully present in the
moment,” said Jamie Pitt, Standardized Patient
Program coordinator. As with real practitioners,
these doctors-to-be must put personal difficulties
aside. Regardless of whether students are having a
bad day, or if someone cut them off in the parking
lot, it all becomes secondary to patients’ needs.
“This changed my idea of what it means to learn
to be a doctor,” said first-year student Giuseppe
D’Amelio. “When we practice on each other, we’re
just going through the motions. It’s very different
when you don’t know what they (the patients) are
going to say.”
Lack of confidence is a common problem, as
is talking about highly personal subjects. As firstyear student Jared Goodman explains: “Unlike
any other conversation you’ve had in your life,
you realize that every sensitive detail comes out
in the first five minutes.”
From bowel movements to sexual behavior, all
topics are open for discussion. “Up until now, social
conditioning taught students not to talk about these
things,” Glueck said. “They’re not always sure what
words to use. That’s where we come in.”
Through video playback, students critically
assess themselves, quickly realizing how often
they say “um,” fidget, click their pens or look
down at the floor. With input from faculty mentors, students go right back in, adjust the approach
Spring 2014

Despite thoughtful scriptwriting, the actors
never know exactly what a student will ask. The
job requires intense concentration. At times, SPs
are interviewed by up to 10 students in succession.
“It’s not about an Oscar-award-winning
performance,” Pitt said. “It’s about a consistent,
reliable portrayal of symptoms. In our auditions,
we look for people who have experience providing
honest, constructive feedback without any
medical biases.”
“You had a good demeanor,” five-year SP veteran Aarya Locker told one student. “I think our
rapport derailed a bit when I asked you a question
and you didn’t know the answer. It’s always fair
to say, ‘I don’t know. Let me research that and get
back to you.’ I would have been floundering a bit,
had I left the office without a solid understanding
of the next steps I should take with my child.”
In one small-group session, a student decided
his peers were “dancing around the subject too
much.” He went into the exam room and flatly told
the SP, “You’ve got cancer.” The SP burst into tears.
“The actors respond exactly to what’s in front
of them,” Glueck said. “And this dramatically
changes what a student can learn. In the student’s
second attempt, he gave the diagnosis and met
the patient where she was, rather than thinking
he knew how it should be done.”
St. Louis’ large professional acting community
offers expertise and versatility. “It’s an absolute
dream to play someone else and see if it’s believable,”
outlook.wustl.edu
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Standing before the wall of local acting talent that fuels the Standardized Patient
Program, coordinator Jamie Pitt (left) reviews a script with Aarya Locker.

LIGHTS, CAMERA,

ACTION !

Sampling the SP repertoire
Bill Worthington, a 56-year-old male,
unemployed, complains of discomfort
in the chest, problems at home.



Jennifer Walsh, a 23-year-old female,
in for a routine checkup, exhibits
signs of abusive physical injuries.



Anna Smith, a 30-year-old female
smoker, presents for shortness
of breath and is discouraged after
a recent failed attempt to quit.
ROBERT BOSTON PHOTOS

ROBERT BOSTON

and try it again. Individualized attention is the
program’s hallmark.
In a word, most students describe those early
experiences as “terrifying”; many walk into the
simulated exam room, nervous and trembling, not
exactly sure what to do. Clipboards are dropped.
Hand sanitizer squirts across the room. Just a
month before, these students were college kids.
Now, they must face a patient — albeit, pretend —
and appear “doctorly.”
The SPs are ready: They’ve memorized symptoms, medication dosages, family medical history
and work-life balance.
Together, Glueck, who enjoys screenwriting,
and Pitt, who acts with local and national theater
companies, have found their calling. The pair
researches and develops a wide range of realistic
scripts, complete with backstories, costume and
props. Actors are carefully coached and scripts
are rehearsed extensively.



Travis Jones, a 16-year-old male,
in for evaluation after his mother
found text messages about suicide;
reports issues at school after
coming out as gay.



Fred Johnson, a 70-year-old male,
in because his wife says he has
trouble remembering things.



Alice McCoy, a 46-year-old female,
nervously awaits biopsy results.
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said Reggi, an actor, director
and producer who trained at
Second City. “I have to step
outside of myself, remain neutral and think about how this
other person would respond.
Certainly, it’s less random
than improv, but it still
requires spontaneity. It’s
where art and science meet.”

High-tech eavesdropping
with a purpose: Alan I. Glass,
MD, watches and listens as
a student group interacts
with a standardized patient.

Program facilitators design simulated cases that
reflect the region’s actual patient population,
deriving input from clinical faculty, and building in elements of religious, ethnic and economic
diversity. They strive to promote the use of appropriate, inclusive language and create scenarios
that may be outside of the students’ comfort zone,
such as a same-sex couple seeking treatment for
an adopted child.
The students are given a host of increasingly
difficult scenarios each year. In their second year,
students simulate an evolving physician-patient
relationship by visiting the same SP multiple
times. Third-year students participate in specialized SP encounters during rotating clerkships.
“The idea is that the more robust you make
the practice environment, the more powerful
and richer the insights,” Glueck said.

“Students bring innate abilities of varying
degrees,” added Alan I. Glass, MD, assistant
vice chancellor and director of Habif Health
& Wellness Center. As a clinical skills section
leader for first- and second-year students,
Glass works closely with the SP program.
“For some students, it’s very easy,” Glass said.
“For others — like in any subject — it takes
more effort. We can teach them skills to be
more effective.”
Glueck cautions, however, it’s not about
making students all the same. It’s about helping
students discover their individual styles so
they can communicate in a way that feels
natural and genuine.
“Over the course of time, we have a record of
multiple patient encounters, and footage of them
interacting with different people,” Glueck said.
“We use this to see where students are struggling
and translate this into actionable steps we can
work on together so they can become the kind
of doctor they want to be.”
Having gone through the entire SP program,
fourth-year student Phillip McGuiness feels he is
ready to face the real thing. “Much of the mental
acrobatics, the awkwardness, is gone. The standardized patients just take it all in stride. These
professionals have played a big part in making
me a more efficient, compassionate doctor.”

Examining “bedside manner”

F

or many medical school alumni,
fellow classmates were the
first “standardized patients.”
“We learned physical exam skills on each
other,” said Alison J. Whelan, MD, senior
associate dean for education at the medical school. “There was no instruction on
communication. Over time, the medical
community has realized that body language does matter — how you sit, how
you look at a patient, how you acknowledge what they are saying.”
Nationally, medical schools are
paying more attention to so-called
“soft” skills and adding standardized
patient programs into their curriculums.
In 2004, the National Board of
Medical Examiners added the Step 2
Clinical Skills component, a pass/fail test
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that is one of three steps students
must complete before applying for a
medical license.
In Step 2, fourth-year medical
students travel to a testing center and
assess 12 standardized patients over
eight hours, with 15 minutes for each
encounter and 10 minutes to record
each patient note.
Prior to taking Step 2, Washington
University requires students to complete an in-house Clinical Competency
Exam — in which they must evaluate six
standardized patients in a day. Not all
medical schools offer this preparatory
advantage for Step 2, the results of
which factor into the residency match.
“The Washington University directors
have developed novel approaches that

“SOME WILL SAY SPs don’t
make up for real patients, which
is true. Our students still round
on hospital patients, but this
gives them a focused, observed
opportunity to practice. Selfassessment is critical to lifelong
learning.” — ALISON WHELAN, MD
serve as a fantastic model for those of
us around the country teaching communication skills to our students,” said
Lisa Bernstein, MD, FACP, associate
professor of medicine and director of
Becoming a Doctor curriculum at Emory
University School of Medicine. Bernstein
also served on an NBME communication
skills task force.
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Taylor Family Institute For
Innovative Psychiatric Research

psychiatry’s
therapeutic frontier
Partnership envisions
novel treatments
for mental illness
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Washington University

Ten investigators with six labs in four
departments will pursue drug discoveries,
novel therapeutics, lifestyle interventions,
and partner with clinical affiliates

P

SYCHIATRIC DISORDERS AFFEC T

more than 80 million Americans, disrupting
their ability to cope with daily living. Left
untreated, the individual and societal costs are
staggering — including disability, unemployment,
substance abuse, physical illnesses, family discord,
homelessness, incarceration and suicide.
Despite the prevalence of psychiatric problems,
there are relatively few effective drugs for treating
them. Even the best drugs are limited, treating a
portion of a person’s symptoms, and many cause
side effects. Novel pharmacological targets remain
the best hope for diminishing the major public
health impact of psychiatric illnesses, but drug
makers have largely abandoned the effort following
failed clinical trials. Development, they have
determined, is too risky and expensive.
Current antidepressants, antipsychotics and
anti-anxiety drugs remain largely unchanged
from past decades. Newer modifications might
be safer or more tolerable, but a truly innovative
drug hasn’t been discovered for 30 years.
“Most of the drugs used today focus on the
same molecular targets in the brain as drugs
that were used in the 1950s and ’60s,” said Charles
Zorumski, MD, the Samuel B. Guze Professor
of Psychiatry and Neurobiology and head of the
Department of Psychiatry.
Learn more about the institute:

taylorfamilyinstitute.wustl.edu

Novel
chemistry

Drug
discovery/
synthesis

Biochemical
testing

A new day may be dawning. Thanks to a visionary
$20-million gift from Andy and Barbara Taylor and the
Crawford Taylor Foundation, the School of Medicine now
is home to the Taylor Family Institute for Innovative
Psychiatric Research. Established in fall 2012, the institute
seeks to advance the science underlying the diagnosis
and treatment of psychiatric illnesses.
Historically, the School of Medicine has led the field of biological psychiatry and was among the earliest to define mental
illness as a disease, not a character flaw — one that could
be investigated in the same way as cancer or heart disease.
The institute unites basic and clinical researchers from
several medical school departments. Together, the investigators bring complementary skills and interests ranging from
medicinal chemistry to animal behavior.
“Our main objective is to find new treatment targets in
hopes of developing more effective drugs,” said Zorumski,
the institute’s director.
Scientists do not yet understand the mechanisms causing
psychiatric illnesses, but Zorumski said it is clear they cannot be explained solely as chemical imbalances, as once was
thought. “Neurochemistry may be involved, but there are
many pathways to explore,” he said.
Psychiatric drugs today often treat symptoms. Instead, the
institute is looking at new therapies to alter the brain networks,
or circuitry, associated with psychiatric disorders. It’s these
networks that are involved in the symptoms of the illnesses.
“Our current view is that major psychiatric illnesses
reflect dysfunction in the brain networks that underlie
cognition, emotion and motivation,” Zorumski said.
Specifically, cognition refers to how people think, perceive
and remember. Emotion is how people attach meaning, and
motivation is how people set and work toward goals. These
processes, which work through various neural pathways that
have yet to be fully understood, often are impaired in mental
illness. “The key is to find treatments (pharmacological
and psychotherapeutic) that modify dysfunctional neural
circuits,” he said.
There is shared circuitry among psychiatric disorders,
although specific illnesses may involve different parts of this
circuitry. For example, changes in the hippocampus, a brain
region involved in memory processing, occur in schizophrenia, depression and post-traumatic stress disorder. Yet, how
this region is involved may differ among the disorders.
Schizophrenia, for instance, signals a breakdown in
thinking and poor emotional responses. It involves three
Spring 2014
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Innovative collaborations

School of Medicine
Testing on ion
channels and
brain cells

Neuroscience Products Company
Testing
in animal
models

Testing
in circuits

types of symptoms: positive, meaning additional symptoms
most people do not typically experience, such as delusions
and hallucinations; negative, meaning symptoms reflecting
deficiencies, such as social withdrawal and an inability to
express emotions; and cognitive, meaning problems with
attention, language and short- and long-term memory.
Current therapies treat schizophrenia’s positive symptoms, but do virtually nothing for the negative or cognitive
symptoms, which hamper one’s ability to function in a job or
relationship. Thus, investigators are looking for treatments
that could address these cognitive and negative symptoms.
Initial research focuses on neurosteroids and oxysterols,
naturally occurring, cholesterol-derived brain chemicals
that may help regulate cognition, emotion and motivation.

I N V E S T I G AT O R S
3
2
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7

4
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10
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1. David Wozniak, PhD; 2. David Reichert, PhD; 3. Charles Zorumski, MD;
4. Alex Evers, MD; 5. Douglas Covey, PhD; 6. Joe Henry Steinbach, PhD;
7. Gustav Akk, PhD; 8. Ziwei Chen, PhD; 9. Yuki Izumi, MD, PhD; and
10. Steven Mennerick, PhD.

In a recent Journal of Neuroscience article, School of
Medicine researchers explained how, in animal models, oxysterols modulate cell receptors involved in learning and memory. These receptors differ from those targeted by current
medications and so they could be useful in the development
of new drugs. “Whether oxysterols are involved in the biology
of schizophrenia is an unanswered question,” Zorumski said.
“Regardless, oxysterols may represent a new approach to
improve brain function in patients with mental disorders.”
Similar considerations can be made for neurosteroids,
which help control how neurons respond to stressors in
the brain. By modulating function of key brain networks,
neurosteroids could serve as effective treatment strategies
in a variety of disorders.
outlook.wustl.edu

Scaled-up
chemistry

Toxicity
testing

Human
trials

Stress, the evidence shows, diminishes neurosteroid
production; decreased neurosteroid levels are linked to
depression, anxiety, alcoholism, epilepsy and Alzheimer’s,
among other disorders.
Replacing these depleted levels with synthetic neuroactive
steroids may help alleviate the altered stress responses and
allow the brain to function more normally.
Researchers are working to identify neurosteroids and
oxysterols in the brain, how they are made and how they
bind to cell receptors. They are studying natural and synthetic versions of these molecules not only as psychiatric
treatments, but also as potential anesthetics.

Although the Taylor Family Institute is new, decades of
prior collaborations brought researchers national recognition
for neurosteroid, neuronal function and anesthesia research.
“We were mostly trying to learn about the anesthetic
effects,” said Douglas F. Covey, PhD. “Now, we’re also looking
at how those molecules might influence psychiatric health.”
Covey, a medicinal chemist and professor of pharmacology in developmental biology, dedicates his career to identifying natural and designing synthetic neurosteroid molecules.
Hexagonal drawings mark notebooks, countertops and the
glass-covered hoods where the molecules are made in his lab.
Covey and his team have built a library of more than
700 compounds. Pointing to a large file cabinet, he halfkiddingly explained that the molecules documented in those
drawers may be good candidates for anesthetics. It’s possible,
he said, that some of the therapies being sought by Taylor
Institute scientists for mental illness already exist there.
Transforming a synthetic molecule into treatment

requires significant resources. Taylor Family Institute scientists are excited about a partnership with Massachusettsbased SAGE Therapeutics, which develops medicines for
central nervous system disorders. SAGE could quickly move
promising therapeutic molecules into clinical trials, and
already has licensed the contents of Covey’s file cabinet.
Institute scientists also are studying potential treatments
developed elsewhere. “The anesthetic drug ketamine may
have the potential to alleviate depression in some patients
with a treatment-resistant form of the disorder,” Zorumski
said. “We’re testing that now, and we will investigate
other novel therapies.
“The field of psychiatry has been doing the same things
over and over again with the same result. We think it’s
time to try a new approach.”
Outlook 17

Accelerating the
critical countdown

STR KE!
P HYSICIANS TODAY KNOW
that time makes all the difference when it comes
to stroke.
The brain is unforgiving to lack of oxygen.
Without it, 1.9 million brain cells die every minute.
But with prompt treatment, significant disability
can be minimized. Hence, “time is brain” now is a
nationally recognized stroke awareness campaign.
Leading School of Medicine specialists have
worked vigilantly to beat the clock. As a result,
patients seen at the Washington University and
Barnes-Jewish Stroke & Cerebrovascular Center
have improved outcomes and are given the best
chance for survival and recovery.
The multidisciplinary team provides some of
the fastest stroke critical care in the U.S. —
assembling in the Emergency Department within
minutes and bringing deep resources to the highstakes task of stroke diagnosis and treatment.
Further, School of Medicine physicians are
helping to shape treatment regionally and
nationally as they define and propose time-critical
standards and continue to pioneer methods of
evaluating and managing stroke.

Expediting response
and treatment

B Y D E B PA R K E R
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Following stroke onset, at-risk brain regions could be revived with prompt treatment.

10

minutes

Some brain regions
(red) already are
irreversibly lost.

1

hour

More time elapses,
more brain tissue dies.
Urgent treatment could
still limit the disability.

3

hours

The window is
closing. Treatment at
this time may result in
moderate disability.

6

hours

Without treatment,
all at-risk tissue has died;
the unfortunate result
may be severe disability.

EMERGENCY IN MOTION:
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Medical personnel participate in a
training exercise for transporting
a stroke patient to the Washington
University and Barnes-Jewish
Stroke & Cerebrovascular Center.

Outlook 19

Stroke’s critical timeline
Most strokes (80% or more) are ischemic
Ischemic Clot blocks blood flow

COMMUNITY GENERAL
Hemorrhagic A brain artery ruptures

A crisis within

Front door to ED door

Brain cells need constant nourishment to survive; it’s delivered by blood via
the arteries. When blood flow is disrupted, myriad cells begin dying, shortcircuiting vital functions. Soon, the person may no longer be able to see,
speak or function in familiar ways.

Seconds count— from the moment of stroke onset, to the
arrival of emergency personnel, through transport to a
hospital. Expertise, equipment and enhanced protocols make
a certified stroke center the destination of choice, even at a

Decreasing door-to-needle times

Transforming a complex process

Washington University physicians at Barnes-Jewish treat
1,600 strokes annually, with four to 10 suspected stroke
patients arriving each day. Despite these high volumes, the
stroke center has achieved one of the fastest “door-to-needle”
averages in the country.
“Door to needle” (D2N) is the
time between the patient’s arrival
at the hospital and IV administraThe national
tion
of the clot-dissolving drug
average exceeds
tPA
(tissue-plasminogen
activator).
one hour
The drug widely is considered the
best course of action in an ischemic stroke, when a clot cuts off
blood flow to parts of the brain.
Ideally, the drug should be
delivered within 60 minutes of
stroke onset, the so-called “golden
hour.” If tPA is given within
BJH D2N
three hours of an ischemic stroke,
median is
one
in three patients will benefit
39 minutes,
and,
within 4.5 hours, one in six
but often
patients
will benefit.
20 minutes
A
patient’s
maximum deficit,
or less
such as paralysis on one side of
the body or slurred speech, happens at the time of stroke
onset when a brain region is starved for oxygen. If blood is
restored quickly, these effects essentially can be undone.
The longer it takes to administer treatment, the more likely
the patient will suffer permanent consequences.
Nationally, the average D2N time is as high as 80 minutes,
according to the American Stroke Association. Today, the
D2N median at Barnes-Jewish Hospital is 39 minutes, with
many patients receiving tPA in 20 minutes or less. The next
goal is to sustain a 30-minute median.

How does a broadscale team — involving emergency medicine physicians, neurologists, neurosurgeons, radiologists,
interventional neuroradiologists and dozens of ancillary
staff — become that nimble?
In 2010, the median D2N time in the Barnes-Jewish
Emergency Department (ED) was 55 to 60 minutes, but the
stroke team determined it could do better by applying lean
manufacturing principles developed by the Japanese car
manufacturer Toyota.
Team members met for two days with lean engineers to
examine each of the 50-plus steps leading to tPA administration. Each step — from patient registration and vital signs
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D2N
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Door to needle
farther distance. However, when patients cannot make
the journey, Washington University stroke physicians
partner with community hospitals in critical care
decisions, using telemedicine (see page 23).

Stroke teams seek to compress the time until treatment begins. Parallel processing
— in which team members work simultaneously to perform a variety of tasks —
facilitates this race against the clock. Innovative approaches to practical problems
help deliver treatment in 30 minutes or less in some cases.

monitoring to labs and imaging — was evaluated from an
efficiency perspective. The objective was to reduce bottlenecks, improve teamwork and communication and ensure
that those caring for patients have easy access to supplies
and equipment.
“We sought suggestions from everyone involved, from
the paramedics who bring in patients, to admitting clerks,
radiology technologists, nurses and physicians,” said JinMoo Lee, MD, PhD, senior author of the study that was published in Stroke. Lee is a Washington University neurologist
at Barnes-Jewish Hospital and director of the Department
of Neurology’s cerebrovascular disease section.
The complex treatment process could be streamlined,
they decided — even before patients arrive at the hospital.

Activating the stroke team en route
In the past, emergency medical services (EMS) personnel
brought the patient to BJH and clinicians there determined
whether the person was having a stroke.
Paramedics now alert BJH staff when a potential stroke
patient is en route. An immediate page goes out to stroke
team members who are ready and waiting when the ambulance or helicopter arrives. EMS partners are well trained and
fully entrusted to activate the team. “One thing we’ve learned
is that you have to cast a very wide net,” Lee said. “We have
a very liberal policy for stroke pager activation. For every
eight activations, only one is treated with tPA. It’s a lesson
to learn: capture as many as you can and consider all
potential candidates.”
Using clinical scales, EMS workers can determine the
severity of a stroke. They also can lower a patient’s high
blood pressure en route, making tPA treatment a more
viable option.
And to help determine time of stroke onset, which is
critical when evaluating treatment options, EMS crews will
begin a new practice: leaving calling cards with witnesses,
encouraging them to contact the stroke team with more details.

Reinventing stroke care
Members of the stroke team and specialty areas: (back row, from left to
right) Renee B. Van Stavern, MD, (neurology); David A. Carpenter, MD,
(neurology); Gregory J. Zipfel, MD, (neurosurgery and neurology);
Colin P. Derdeyn, MD, (neuroradiology, neurology, neurosurgery);
and Andria L. Ford, MD, (neurology); and (front row) Peter D. Panagos,
MD, (emergency medicine and neurology); and Jin-Moo Lee, MD, PhD,
(neurology and radiology).
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TEAMWORK
Acute stroke team members converge
at the CT scanner upon patient arrival;
ED nurses respond with carefully
choreographed, pre-planned routines.

COMMUNICATION, ANALYSIS, DECISIONS
Emergency medical transport leader conveys patient
information to stroke team physicians; physicians
perform rapid neurological tests, assessing lab results
and responding with real-time decisions.

DATA & DRUG DELIVERY
Patient is stabilized and ready for a brain
scan and its immediate review by physicians.
Intravenous drip is in place and ready to
administer therapeutic drug.

Orchestrating a precision “parallel response”
Working in concert
Previously, suspected stroke patients first were taken to a
trauma bay for history taking, blood draw and neurological
exam. From there, they were transported to an ED-dedicated
CT scanner to determine whether the stroke was ischemic
or hemorrhagic (ruptured artery), before being taken back
to the trauma bay for further assessment.
Based on recommendations of the process improvement
team, paramedics now sidestep the trauma bay and take the
patient directly to the CT scanner for prompt evaluation.
“We can obtain the story, begin the neurological exam,
initiate patient registration, complete the brain imaging
within minutes — all in the CT scanner room — quickly
determining if the patient meets tPA criteria,” said Peter D.
Panagos, MD, associate professor of emergency medicine
and neurology. “Eliminating these extra steps saves 12
to 15 minutes.”
Using parallel processing, steps previously performed
in sequence are carried out simultaneously with additional
staff. Every team member has a role that is not duplicated.
Instituting lab tests that could be performed at the bedside
reduced time spent waiting for results.
22 Washington University School of Medicine

Meanwhile, interventional radiologists are on standby
for patients who do not respond to tPA. These patients may
benefit from endovascular interventions using tools that
can retrieve clots or open arteries in other ways. In the past
few years, these devices have shown great improvement,
according to Colin P. Derdeyn, MD, professor of radiology
and director of the stroke and cerebrovascular center.

Improving patient outcomes
Following months of refinement, 78 percent of patients now
are treated within “the golden hour” — up from 52 percent
— and team members continue to speed the process.
“This is only one of our lean process success stories,” Lee
said, “but it nicely demonstrates how lean transformation
can improve processes across the spectrum of stroke care.”
After the patient is admitted to the hospital, the team
puts much of its emphasis on preventing life-threatening
complications and determining why the stroke occurred
in the first place, taking steps to prevent the high risk
of recurrence. For instance, as atrial fibrillation is a
common stroke trigger, the patient may be placed on
an anticoagulant.
Spring 2013

Striving toward personalized care
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Remarkably, School of Medicine researchers are beginning
to suggest that some of those patients who miss the optimal
three-hour treatment window may still have hope. In limited
cases, physicians here are, in effect, throwing out the clock.
“Every stroke case is different,” Lee said. “Some patients
may have just enough blood flow to preserve brain tissue —
even after six hours. Other patients might not have viable
brain tissue after one hour.” Future technologies may provide a more sophisticated determinant.
Lee is leading a study searching for new methods to
image and identify salvageable tissue.
Oxygen metabolism is a good indicator of brain viability.
Lee and Andria Ford, MD, assistant professor of neurology,
devised a quantitative map of oxygen metabolic index (OMI)
viewable on MR scans. As OMI drops, there is a threshold
at which brain cells will stop working but may still be alive,
and another threshold past which tissue is dead. This initiative is based on the theoretical work of radiology professor
Dmitriy Yablonskiy, PhD, and performed in close collaboration with Weili Lin, PhD, and Hongyu An, DSc, at the
University of North Carolina-Chapel Hill.
Initial results suggest this six-minute scan accurately
highlights brain areas that may survive if successfully
reperfused. Knowing this would allow stroke teams to more
effectively determine the appropriate course of action —
tPA, interventional radiology — or perhaps some treatment
that hasn’t yet been developed.
“It’s all about providing the right care to the right
patient at the right time,” Lee said.

Seeing ways to save more brain

SOME MATERIAL FOR THIS STORY PROVIDED BY ST. LOUIS FREELANCE WRITER JO SELTZER.

Advanced MR images indicating oxygen metabolism levels in the
brain (red indicates the highest level) show promise for facilitating
faster, better-informed and more precise stroke treatment decisions.

Nearly two hours
after a stroke

Six hours
and counting

One month
afterward

A massive brain region
(left) starves for oxygen;
restoring blood flow
could prevent severe
permanent disability.

A clot-busting drug
therapy successfully
restores oxygenated
blood to all but the
encircled region.

The area of permanent
damage corresponds to
the high-risk region that
was shown by the sixhour metabolism scan.
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Renee B. Van Stavern, MD, above, and Peter Panagos, MD, lead the
stroke center’s telemedicine network with regional hospitals.

Reaching beyond the hospital

I

n 2013, Barnes-Jewish
became the first comprehensive stroke center in
Missouri and among the
earliest in the country.
The Joint Commission
and the American Heart
Association/American Stroke
Association established the
advanced certification to recognize hospitals that achieve
higher standards and meet
criteria for resources, staff and
training essential to treating
the most complex stroke cases.
Comprehensive stroke centers
provide the full spectrum of
care, from diagnosis to specialized rehabilitation. David
A. Carpenter, MD, associate
professor of neurology, directs
Barnes-Jewish Hospital’s comprehensive stroke center.
Missouri’s Time-Critical
Diagnosis statute dictates that,
in the same way car crash victims must be taken to trauma
centers, stroke patients now
must be taken to certified
stroke centers, sometimes
bypassing closer hospitals.
Time lost in transit might
be made up with resources
and expertise. Washington
University faculty members
were key in crafting this legislation; several sit on state
review boards, traveling to
various hospitals to evaluate
their processes.

The team shares best
practices and, through webbased communications,
conducts real-time patient
assessments with regional
emergency departments, particularly those in rural counties
that may have no immediate
access to neurologists or other
specialty physicians.

100
The stroke center’s
patients originate
from 100 hospitals
in 7 states.

Some hospitals are not
equipped to administer tPA
or make acute-care decisions;
others can administer tPA and
transfer patients to comprehensive stroke centers. Because
of these collaborations, some
hospitals previously bypassed
by paramedics now are
equipped to deliver care for
milder strokes, while severe
strokes still are best served
at comprehensive centers.
“This is about how you
can impact remote communities with a collective effort,”
Lee said. “This major push has
made all the difference. Timecritical diagnosis has prompted
us to rethink how we handle
regional patient flow.”
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matchday
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The next stage
N MARCH 21, graduating medical students at

Washington University opened envelopes
revealing where they will spend the next
years training in their chosen specialty. During
Match Day, held annually in March, thousands of
fourth-year medical students across the U.S. simultaneously learn their results from the National
Resident Matching Program. School of Medicine
graduates are highly successful in obtaining

ALABAMA
Birmingham
University of Alabama
Medical Center
INTERNAL MEDICINE

Lauren Kelly Shea

ARIZONA
Phoenix
St. Joseph’s Hospital/
Barrow Neurological Institute
N E U R O LO G I C A L S U R G E R Y

Jakub Godzik

CALIFORNIA
Camp Pendleton
Naval Hospital Camp Pendleton
FA M I LY M E D I C I N E

Jennifer Mae Jupitz

Irvine
University of California–
Irvine Medical Center
INTERNAL MEDICINE

Miriam Shugufa Nojan

Los Angeles
Harbor–UCLA Medical Center
INTERNAL MEDICINE

Nichelle Megowan

San Diego
Scripps Mercy Hospital
INTERNAL MEDICINE

Nilika Chaudhary

San Francisco
University of California–
San Francisco

INTERNAL MEDICINE
PRIMARY

Elisabeth Thames Boehme
Askin
Elaine Ching-Feng Khoong
O T O L A R Y N G O LO G Y

Philip Laurence Perez
PAT H O LO G Y

Gregory Richard Bean

Stanford
Stanford University Program
A N E S T H E S I O LO G Y

Francesca Betti
PAT H O LO G Y

Ansuman Satpathy

COLORADO
Denver
Denver Health Medical Center
EMERGENC Y MEDICINE

Robert Jared Klemisch

CONNECTICUT
New Haven
Yale–New Haven Hospital
GENERAL SURGERY

Raymond Alexander Jean
O P H T H A L M O LO G Y

Jenna May Kim

FLORIDA
Miami
Jackson Memorial Hospital
A N E S T H E S I O LO G Y

Paul Scott McNair
INTERNAL MEDICINE

Nhi Hoai Nguyen

GENERAL SURGERY

Jhoanne Lynne Bautista

GEORGIA
Atlanta

MASSACHUSETTS
Boston

Emory University
School of Medicine

Beth Israel Deaconess
Medical Center

EMERGENC Y MEDICINE

Akshay Ganju
P S Y C H I AT R Y

Georgina Elizabeth Hartzell

Morehouse School of Medicine
GENERAL SURGERY
PRELIMINARY

Michael Brandon Williams

INTERNAL MEDICINE

Philip Scott Kemp
Lauren Margaret Yang
OBSTETRICS AND GYNECOLOGY

Jennifer Chu

Brigham & Women’s Hospital
EMERGENC Y MEDICINE

Rittik Chaudhuri

INTERNAL MEDICINE

ILLINOIS
Chicago

David Morton Rubins

Rush University Medical Center

Ryan Everett Anderson

O P H T H A L M O LO G Y

Afua Helen Annor

Schwab Rehabilitation Hospital
PHYSICAL MEDICINE AND
R E H A B I L I TAT I O N

Vovanti Tivoli Jones

University of Chicago
Medical Center
INTERNAL MEDICINE

Mary Clare Masters
P E D I AT R I C S

Leena Vikas Padhye
R A D I AT I O N O N C O LO G Y

Sandeep Ramesh Bhave

University of Illinois
College of Medicine
GENERAL SURGERY

Braden Noah Juengel

LOUISIANA
Shreveport
Louisiana State University
Health Sciences Center
O T O L A R Y N G O LO G Y

Zao Yang
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competitive training programs. The largest contingent will continue training locally: Twenty-eight
at Barnes-Jewish Hospital and two at St. Louis
Children’s Hospital. The next largest group is
headed to Harvard Medical School. Of the class,
31 graduates will train in internal medicine,
followed by nine each in pediatrics and general
surgery, eight in emergency medicine and seven
each in anesthesiology and pathology.
Tufts Medical Center
O R T H O PA E D I C S U R G E R Y

Geoffrey Evan Stoker

MARYLAND
Bethesda
National Institute of Mental Health
P O S T D O C T O R A L F E L LO W S H I P

Jonathan David Power

MICHIGAN
Ann Arbor
University of Michigan Hospitals
EMERGENC Y MEDICINE

INTERNAL MEDICINE
PRIMARY

Arun Ganti

N E U R O LO G Y

Stephanie Lynn Skala

Illya Tolokh
PAT H O LO G Y

Kristine Shannon Wong

Boston Children’s Hospital
P E D I AT R I C S

Alexandra Hathaway Baker

Harvard Longwood Psychiatry
P S Y C H I AT R Y

Elizabeth Fenstermacher

Massachusetts General Hospital
A N E S T H E S I O LO G Y

Albert Mao

D I A G N O S T I C R A D I O LO G Y

Ravi Gottumukkala
Gary Xiaoshi Wang
GENERAL SURGERY

Charles Gerard Rickert

PAT H O LO G Y

Royal Oak
Beaumont Health System
OBSTETRICS AND GYNECOLOGY

Lauren Elizabeth Perlin

MISSOURI
St. Louis
Barnes-Jewish Hospital
A N E S T H E S I O LO G Y

Jacob Martin Basak
Kyle Glenn Jacobsen
Nisha Jain
D E R M AT O LO G Y

Lu Chen
Rachel Lea Kyllo
May Meishu Zhang
D I A G N O S T I C R A D I O LO G Y

INTERNAL MEDICINE
PRIMARY

Marina Igorevna Mityul
Ryan P. Rimer

PAT H O LO G Y

Stephanie Kae Charshafian

P S Y C H I AT R Y

Linda Xiaobo Jin
Jared Michael McAllister

Christopher Tsung-jer Chen
Athena Lee Chen
Erin Elizabeth Dowd

EMERGENC Y MEDICINE
GENERAL SURGERY
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MD/PhD student Radhika Jagannathan learned
she will be going to New York Presbyterian
Hospital–Weill Cornell Medical Center. Moments
later, she received a surprise marriage proposal
from her longtime boyfriend, Tom Wilson.
INTERNAL MEDICINE

Amit Indra Bery
Jacqueline Wenjia Chen
Raymond Bamvi Fohtung
Catherine Teresa Jordan
Niall Prendergast
Samuel Wayne Reinhardt
Joshua Michael Saef
Michael Edward Tang
Peter Hou Yu Yen
Kevin Zheng Yuan
N E U R O LO G Y

Osvaldo Jose Laurido-Soto
OBSTETRICS AND GYNECOLOGY

Lucy Liu

O R T H O PA E D I C S U R G E R Y

Melissa Anderson Wright
P S Y C H I AT R Y

Sarah Elizabeth Jeann
Donaldson
R A D I AT I O N O N C O LO G Y

Lauren Elizabeth Henke
U R O LO G Y

Joseph B. Song

St. Louis Children’s Hospital
P E D I AT R I C S

Stephen Charles Gradwohl II
Hallie Faryn Morris

Washington University
School of Medicine
O P H T H A L M O LO G Y

Cynthia Lee Montana

NEW HAMPSHIRE
Lebanon
Dartmouth-Hitchcock
Medical Center
D I A G N O S T I C R A D I O LO G Y

Ellen Yulin Chang

NEW MEXICO
Albuquerque
University of New Mexico
School of Medicine
EMERGENC Y MEDICINE

Heather Nicole Orth
PAT H O LO G Y

Andrew Warren Judd

NEW YORK
New York
Hospital for Special Surgery
O R T H O PA E D I C S U R G E R Y

Jeffrey Gei-Hun Stepan

Icahn School of Medicine/
Mount Sinai
O T O L A R Y N G O LO G Y

Katelyn Andrea Ostendorf

New York Presbyterian Hospital–
Columbia
INTERNAL MEDICINE

Nicholas A. Hoerter

New York Presbyterian Hospital–
Weill Cornell Medical Center
INTERNAL MEDICINE
RESEARCH

Agata Agnieszka Bielska
N E U R O LO G Y

Radhika Jagannathan

New York University
School of Medicine
GENERAL SURGERY

Charles Robert Hong
INTERNAL MEDICINE

Aram Kim

OHIO
Cincinnati
Cincinnati Children’s Hospital
P E D I AT R I C S

Mahil Rao
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Competitive
Bhangra dancer
Ravi Gottumukkala
celebrates; he
is headed to
Massachusetts
General Hospital.

Jacqueline Chen, left, and Linda Jin are staying
in St. Louis: Both will train at Barnes-Jewish
Hospital in internal medicine and general
surgery, respectively.

Cleveland

Pittsburgh

Houston

Case Western/Metro Health
Medical Center

University of Pittsburgh
Medical Center

Baylor College of Medicine

OBSTETRICS AND GYNECOLOGY

Stephanie Rose Thomas

Case Western/University
Hospitals
PLASTIC SURGERY

Yuewei Wu-Feinberg

Columbus
Ohio State University
Medical Center
EMERGENC Y MEDICINE

David Christopher Harris

OREGON
Portland
Oregon Health and Science
University
O P H T H A L M O LO G Y

Iris Lee
Brigid Kathleen Marshall

PENNSYLVANIA
Philadelphia
Hospital of the University
of Pennsylvania
FA M I LY M E D I C I N E

Michael J. Scott

GENERAL SURGERY

Victoria Merrill Gershuni

Ariel Maia Lyons-Warren

PAT H O LO G Y

Matthew Terrence Humbert

P E D I AT R I C S

Sara Xu Chen

Diana Souza DeAndrade
Thomas Michael Pearce
Michael C. Verre
POSTDOC TORAL POSITION

Jordan John Williams

SOUTH CAROLINA
Charleston
Medical University of
South Carolina
P S Y C H I AT R Y

Alton Cleotha Williams III

TENNESSEE
Nashville
Vanderbilt University
Medical Center
P E D I AT R I C S

Andrea Nicole Lambert

TEXAS
Dallas
University of Texas
Southwestern Medical School
INTERNAL MEDICINE

INTERNAL MEDICINE

Rabia Salman Akhtar
Usman Akhtar

N E U R O LO G Y

P E D I AT R I C S

Allison Jan Steinmetz
Laura Esther Mainardi
Villarino

C H I L D N E U R O LO G Y

A N E S T H E S I O LO G Y

Rachael Celeste Johnston

EMERGENC Y MEDICINE
INTERNAL MEDICINE

San Antonio
University of Texas
Health Science Center
OBSTETRICS AND GYNECOLOGY

Brittanie Broersma

UTAH
Salt Lake City
University of Utah
Affiliated Hospitals
P E D I AT R I C S

Sarah Nicole Cilvik

WASHINGTON
Seattle
University of Washington
Affiliated Hospitals
INTERNAL MEDICINE
PRIMARY

Phillip Andrew McGuiness

NORWAY
Oslo
University of Oslo
OBSTETRICS AND GYNECOLOGY

Heidi Elisabeth Fjeldstad

U R O LO G Y

Marshall Channing Strother

Scheie Eye Institute
O P H T H A L M O LO G Y

Iga Natalia Wegorzewska
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classnotes
1940 S
James Read, MD 43, HS 44, is retired and
living in New Jersey. His hobbies include
sketching and drawing classes, swimming
and croquet. Read is a member of the
health-care committee for the retirement
community where he resides. He has been
honored for philanthropic initiatives and
helping oversee conditions and issues of
the retirement community.

1950 S
John Denman, MD 52, is retired from
active practice, but still spends time in the
medical community as a medical school
volunteer and as president of a retired
physicians’ group. He plays clarinet in a
local band; other hobbies include tennis
and golf. Denman loves spending time
with his children and grandchildren.
Paul DeBruine, MD 59, is a retired anesthesiologist and a trustee emeritus of
the Elmhurst College Board of Trustees.
Elmhurst College, DeBruine’s undergraduate institution, awarded him an honorary
Doctor of Science at its 142nd commencement exercises in June 2013.

1960 S
Lynn Rosenstock, MD 63, is retired, but
stays active as a voluntary clinical professor of anesthesiology at Stanford
University School of Medicine. She volunteers weekly at a free clinic for the working
poor, at her local library and on the board
of the local League of Women Voters.
Charles Shaeffer, MD 64, a cardiologist at
Eisenhower Medical Center in California,
was invited to participate in a White
House briefing on behalf of the American
Heart Association. With more than three
decades of service to the AHA, Shaeffer
has made contributions toward tobacco
control, obesity prevention and heart disease and stroke research funding. He has
been awarded the AHA Gold Heart Award,
Volunteer Advocate of the Year Award and
the Jefferson Award Certificate.
26 Washington University School of Medicine

Gary Ratkin, MD 67, retired from hematology-oncology practice in June 2012 but
continues to provide leadership to the
Palliative Care Program at Missouri Baptist
Medical Center. He also is a volunteer
physician and medical director at Casa de
Salud, a low-cost primary care clinic serving immigrants in the St. Louis area.

1970 S
Patricia Penkoske, MD 74, was presented
with Lindenwood University’s Alumni
Merit Award. She was one of its first graduates to become a physician.
Mark Frisse, MD 78, EMBA 97, is the
Accenture Professor of Biomedical
Informatics and director of regional informatics for Vanderbilt University. He was
elected to the Institute of Medicine in
2013. Frisse focuses on the intersection
between health-care informatics, economics, policy and health-care transformation.

1980 S
Carol North, MD 83, is serving as president
of the North Texas Society of Psychiatric
Physicians and will serve as president
of the American Psychopathological
Association in 2015.
Wilson Compton, MD 86, was appointed
deputy director of the National Institute
on Drug Abuse, part of the National
Institutes of Health. Since 2002, he has
served as director of NIDA’s Division of
Epidemiology, Services and Prevention
Research. In 2013, he was one of 10 to
receive the Health and Human Services
Secretary’s Meritorious Service Award.
William Powderly, HS 87, the J. William
Campbell Professor of Medicine, was
appointed with tenure at Washington
University School of Medicine. He also
directs the Institute for Public Health.

1990 S
David Hunstad, MD 95, was promoted with
tenure to associate professor of pediatrics
at the School of Medicine.

2000 S
Betsy Peterson, MD 02, opened a solo
pediatric practice after residency in 2005.
Community Pediatrics in Wisconsin now
has two locations, three pediatricians,
two pediatric nurse practitioners and
12 other staff. She also is involved with
the Wisconsin chapter of the American
Academy of Pediatrics and was elected to
the board of directors in 2012. Peterson
reports that the puppy she got during her
first year of medical school just turned 15!
Erica Roger, MD 04, HS 08, is a St. Louis
dermatologist and was the American
Academy of Dermatology’s Shade
Structure Grant Program recipient in 2013.

In Memory
Joseph Pollock, MD 38, LA 38
Pollock died Saturday, June 22, 2013, in
Santa Barbara, Calif., at age 99. After earning a medical degree, Pollock specialized
in abdominal surgery, serving as chief
of surgery at several hospitals, including Cedars of Lebanon. He taught at the
University of Southern California Medical
School and served as a deputy coroner.
Besides practicing medicine for almost
50 years, Pollock ran Triangle Steel and
Supply and founded, along with his wife,
Helene, the Music Center of Los Angeles.
He was active in the Los Angeles County
Museum of Art and the Mark Taper
Forum and served as chairman of the
Santa Barbara International Film Festival.
Through the Joseph and Helene Pollock
Foundation, he helped create the Pollock
Theater at the University of California,
Santa Barbara.
Marian Green, NU 48
Green died Saturday, June 22, 2013, in
Columbia, Mo., at age 85. Green was an
American Airlines stewardess in the late
1940s before becoming a registered nurse
at Barnes Hospital during the 1970s and
early 1980s. After retirement, she was an
active member of the Kiwi Club and the
Kings’ Daughters in Columbia.
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David Kipnis, MD
Kipnis died Wednesday, Feb. 5, 2014, at
86. He began his career at WUSM in 1955
as a research fellow and later was named
director of the Clinical Research Center
and Adolphus Busch professor and head
of the Department of Medicine. During
his tenure, he established critical links
between research and patient care, building collaborations among the Department
of Medicine and the school’s basic science
departments. His many achievements
include overseeing construction of the
Clinical Sciences Research Building and
establishing a diabetes and endocrinology
center at WUSM. Washington University
honored Kipnis with Second Century and
Distinguished Service awards. He also
received honors from the Association of
American Physicians, American Diabetes
Association, Endocrine Society, Institute of
Medicine, American Academy of Arts and
Sciences, National Academy of Sciences
and American College of Physicians.
Ervin Lipschitz, MD 49, LA 49
Lipschitz died March 14, 2013. He earned
undergraduate and medical degrees
from Washington University, completed
an internship in internal medicine at
Barnes Hospital and served as an assistant
resident in medicine at Jewish Hospital.
Lipschitz completed a psychiatry residency
at The Menninger Clinic in Topeka, Kan.
He practiced medicine from 1949-2010.
He worked in private practice and as a
staff psychiatrist at VA Medical Centers
in St. Louis, as a consulting psychiatrist
for St. Louis Community College and
Maryville University and as director of the
psychiatric services section at Washington
University Student Health Services. He was
on the faculty of Saint Louis University and
Washington University.
Robert Paine, HS 49
Paine died Sunday, June 16, 2013. At
age 16, he attended Harvard University,
earning bachelor’s and medical degrees
before moving to St. Louis to complete his
residency. Paine served in the U.S. Army
Air Corps during World War II. Afterward,
he received a Rockefeller fellowship in
cardiology at the School of Medicine. He
served as founder and chief of cardiology for more than 40 years at St. Luke’s
outlook.wustl.edu

Hospital, clinical professor of medicine
at the School of Medicine, fellow of the
American College of Physicians and fellow
of the American College of Cardiology.
James Adams, MD 55
Adams died Thursday, May 9, 2013, at
the age of 83. After training at the School
of Medicine and serving as a U.S. Army
captain, Adams taught on the University
of Rochester faculty for nearly 51 years. As
a professor of surgery, he cared for many
patients and trained hundreds of residents
and medical students.
Richard A. Lattner, DE 56
Lattner died Saturday, April 20, 2013, at
age 83. He practiced dentistry in St. Louis
for more than 30 years and taught at
Washington University School of Dentistry
until his retirement in 1989. Lattner, a commander in the U.S. Naval Reserve, was buried with full military honors at Ft. Jackson
National Cemetery in South Carolina.
Robert Christie Wray Jr., MD 63
Wray died Monday, Nov. 18, 2013. After
completing medical school, Wray was on
the faculty at Washington University, the
University of Rochester School of Medicine
and the Medical College of Georgia, where
he was chief of plastic surgery. Wray
served on the American Board of Plastic
Surgery, the Western Trauma Association,
the Association of Academic Chairmen
in Plastic Surgery and the American
Association of Plastic Surgeons, holding a
number of leadership positions.
David Hussey, MD 64
Hussey died Wednesday, April 17, 2013.
After earning a bachelor’s degree from
Beloit College, he attended Washington
University School of Medicine. He completed a residency at the University
of Iowa and a fellowship in radiation
oncology at the University of Texas M.D.
Anderson Hospital and Tumor Institute,
where he was a faculty member until
1983. He also taught at the University of
Iowa and the University of Texas Health
Science Center. Hussey was active in
several national organizations, including
the American College of Surgeons and
the American Board of Radiology.

Isaac Boniuk, HS
Boniuk died Thursday, Aug. 1, 2013. After
attending Dalhousie University for undergraduate and medical degrees, Boniuk
completed an ophthalmology residency at
the University of California, San Francisco,
and a retinal fellowship at Barnes Hospital.
He served as a captain in the U.S. Army
Medical Corps in Okinawa for two years. For
38 years, he practiced at Retinal Consultants
in St. Louis, in addition to publishing many
articles on clinical ophthalmology research.
Susan Kennedy, MD 72, HS 76
Kennedy died Tuesday, July 9, 2013, at the
age of 65. She earned a bachelor’s degree
from the University of Oklahoma, before
attending medical school at Washington
University. Kennedy owned and operated
several dermatology clinics in Arizona.
She was a successful golfer and qualified for the USGA Women’s Amateur Golf
Tournament in 1964 and 1984.
Robert Burgerman, EN 79, MD 84, HS 85
Burgerman died Friday, July 12, 2013,
at age 54. He earned degrees in electrical engineering and medicine from
Washington University, completed a
neurology residency and EEG fellowship
at the University of Maryland, followed by
an epilepsy fellowship at the University of
Pennsylvania. Burgerman practiced medicine for 21 years in Sacramento, Calif., was
founder and medical director of the Sutter
Comprehensive Epilepsy Program and
medical director of Sutter Neurodiagnostic
Laboratories. He was on the medical staff
at Mercy General Hospital and UC Davis
Medical Center.
Harvey Saligman
Saligman died Friday, Nov. 15, 2013,
at age 75. He was a longtime friend of
Washington University and served on its
Board of Trustees for more than 25 years.
During this tenure, Saligman raised and
donated millions of dollars for scholarships, new facilities and research at
Washington University. In 2009, Saligman
and his wife, Linda, established the Harvey
and Linda Saligman Multiple Myeloma
Research Fund, which, in less than five
years, began yielding results, including
clinical trials for two new drugs and a large
myeloma tissue bank for ongoing research.
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Together.
Together, we learn.
Together, we discover.
Together, we create.
Together, we heal.
Together, we innovate.
Together, we lead.
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A R E P O R T F R O M T H E S C H O O L O F M E D I C I N E C A M PA I G N CO - C H A I R S

Making progress through Leading Together:
The Campaign forWashington University.

I

t is a pleasure to report to you on the success to date of
Leading Together: The Campaign for Washington University.
We are at the midpoint of the campaign and more than
halfway to achieving our goal. The response to the campaign
reflects a tremendous confidence in the School of Medicine,
and it positions us well for the remainder of the campaign.
We are grateful for your generosity.
There is no question that every gift matters. Funds
directed toward research can be strategically applied to
leverage additional funding from other sources. Seed
funding for pilot projects that result in proof of concept for
scientific ideas can position researchers to obtain substantial
funding from government agencies and corporate sponsors.
Financial support
Progress toward the campaign goal of $1.1 billion*
through endowed
$713,911,763
professorships, as
well as endowed
Time elapsed during the 112-month campaign
fellowships and
58 MONTHS
scholarships, is
* Totals as of Dec. 31, 2013
critical to retaining
and recruiting the most important resource of the School
of Medicine: the extraordinary people who lead the field in
teaching and research.
We look forward to the second half of the campaign
and to establishing a new record level of support. Please
consider participating if you have not done so already, as
together, we ensure the future success of the School of
Medicine and its myriad efforts to improve human health.
George W. Couch III • David C. Farrell • Gordon W. Philpott, MD
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C A M PA I G N CO - C H A I R S
GEORGE W. COUCH III
Trustee of Washington University
DAVID C. FARRELL
Emeritus Trustee of Washington University
GORDON W. PHILPOTT, MD ’61, HS
Former Chief of Surgery at Jewish Hospital
Former Trustee of Washington University

CO M M I T T E E M E M B E R S
ANDREW CHAN, MD/PhD ’86, HS ’89
Senior Vice President, Genentech
ROBERT G. CLARK
Chairman and CEO, Clayco Corporation
PETER CORR, PhD
Co-Founder, Auven Therapeutics
Management LLLP
LOUIS KUCHNIR, PhD, MD ’97, HS
Private Practice Physician
JAMES S. MCDONNELL III
PHILIP NEEDLEMAN, GR ’99
Emeritus Trustee of Washington University
WILLIAM A. PECK, MD, HS ’63
Director, Center for Health Policy
Former Dean and Executive Vice Chancellor
SHIRLEY SAHRMANN, PT ’58, MA ’71, PhD ’73, HS
HARVEY SALIGMAN*
Trustee of Washington University
CRAIG D. SCHNUCK
Chairman, Schnucks Markets Inc.
Trustee of Washington University
SALLY SCHNUCK, OT ’78
LARRY J. SHAPIRO, AB ’68, MD ’71
Executive Vice Chancellor for Medical Affairs
and Dean, School of Medicine
WILLIAM P. WIESMANN, MD ’72, HS
President and Founder, BioSTAR Group
Trustee of Washington University
PAMELA GALLIN YABLON, AB/BS ’74, MD ’78
Director, Pediatric Ophthalmology,
Professor of Pediatrics,
Columbia Presbyterian Medical Center
* Deceased
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A LETTER FROM THE DEAN OF THE SCHOOL OF MEDICINE

LARRY J. SHAPIRO, MD
Executive Vice Chancellor for Medical Affairs
and Dean, School of Medicine
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Washington University School of Medicine has an enviable
record of achievement. We excel in each of our areas of
endeavor. We have enormous assets in people, facilities and
reputation. We have a tradition and a culture that places a high
value on excellence in everything that we do. All of this requires
significant financial resources beyond those currently available.
This campaign and your participation can tip the balance
toward achieving even greater success.
Eighteen Nobel Laureates have been associated with
Washington University School of Medicine. We are world
leaders in genetics and genomics and their application in the
development of personalized medicine, specifically with regard
to improving outcomes in cancer care and prevention. We
have long been leaders in neuroscience and have conducted
pioneering research in the area of Alzheimer’s disease. We are
one of the world’s preeminent institutions in the development
and application of imaging techniques and annually rank
among the top medical schools in the U.S. in the amount of
competitively awarded funding that we secure from the
National Institutes of Health.
However, today there is a confluence of external and internal
factors that require focused attention, strategic planning and
action. An aging population in America — and a growing
underserved population worldwide — have pushed traditional
health-care delivery to a breaking point. We must be prepared to
succeed in new models for the delivery of patient care. As well,
funding from the National Institutes of Health has declined over
the past decade. As a result, important work by our physicianscientists to alleviate suffering and disease is being delayed or
deferred. Our response to the challenges that we face today will
determine how successful we will be in the future.
The continued support from our alumni and friends has
never been more important, and I am confident that together we
will continue to flourish, even in a dramatically changing world.

Spring 2014

ROBERT BOSTON

Susie and Gordon Philpott, MD, with annual scholarship recipients, left to right: Kelsey Rebehn, Jacob Witt, Taleef Khan, Lucas Dvoracek,
Ross Vyhmeister, James VandenBerg and Miles Bichanich.

Supporting a dream
Meeting the growing need for scholarships

is an important challenge for the future and is a
priority of the Leading Together campaign.
Gordon W. Philpott, MD ’61, emeritus
professor of surgery, is co-chairing the School
of Medicine’s scholarship initiative committee.
This initiative has secured nearly $22 million
in endowed support toward a campaign goal of
$40 million for endowed student
support. Moreover, very significant
annual funds for scholarships have
been received.
Gordon and his wife, Susie, have
supported their own annual and
endowed scholarships. As Gordon
explains, “We made a decision to add
to
the endowed scholarship started
Scholarships allow
by my mother. In addition, my sister,
students to pursue
Ann Augustin, and I wanted to make
career paths based on
it a major scholarship to provide full
support for a student.”
passion, not on income.
Tom Shane, MD ’06, was the
first recipient of the Philpott Family
Scholarship, and Kavitha Rajeswari Sivaraman,
MD ’10, was the second. Fourth-year student
Marshall Strother now holds the scholarship.
“We get to know the endowed scholarship students
over a period of years, have dinner with them and

Together,
we learn.
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meet their friends,” Gordon said. “They even
have invited us to their weddings, so they really
become part of the family.”
“It is fun to get to meet the new annual scholarship students each year and it keeps us in touch
with the school,” Susie added.
Scholarship support reduces debt upon graduation and has an immediate impact on students’
lives. According to the Association of American
Medical Colleges, medical students graduating in
2013 had an average of nearly $170,000 of education debt. The average indebtedness of Washington
University School of Medicine Class of 2013
graduates was just under $100,000 — more than
40 percent less than the national average.
Scholarships also are key to allowing future
generations of students to pursue career paths
based on passion, not on potential income.
“When applying to medical schools, I braced
myself for the possibility that I would be forced to
choose between a school I wanted to attend and a
school I could afford to attend,” said second-year
student Ross Vyhmeister. “Scholarship funds made
it possible for me to have the best of both worlds,
enabling me to attend my first-choice school without excessive debt. I am grateful to be part of such
a supportive community and look forward to the
day when I can donate to a scholarship fund.”
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John Morris, MD, and others at the Charles F. Knight Alzheimer’s Disease Research Center, are looking at treatment methods
that may help prevent the disease. He and Randall Bateman, MD, have enlisted volunteers worldwide to participate in a trial.

Effective treatments
Up until now drug trials to treat Alzheimer’s
disease after dementia onset have been ineffective;
such discouraging results are not new to the
long-fought Alzheimer’s disease field. However,
at Washington University School of Medicine,
a recently launched drug trial — in those who
do not yet have outward symptoms — may offer
the possibility of success.
Ten years ago, Olga Mohan,
a California pediatrician in the
prime of her career, found difficulty
expressing her thoughts in words
and was diagnosed with Alzheimer’s
in her early 50s. “It is a horrible
disease,” said her husband, Fred
Simmons. “We want others who
Recently launched drug
experience
it through their family
trials — in those who do
to have the best chance to avoid it.”
not have outward symptoms
In learning about John C. Morris,
of Alzheimer’s —may offer
MD, and his leading-edge Alzheimer’s
research, the couple decided to
the chance of success.
make a gift. Morris, the Harvey A.
and Dorismae Hacker Friedman
Distinguished Professor in Neurology, directs
the university’s Charles F. Knight Alzheimer’s
Disease Research Center.
“I believe John Morris is of the highest integrity and intelligence,” Simmons said. “I learned

Together,
we discover.
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exactly what John was
doing, research-wise,
and realized that it
could have far-reaching
implications.”
Through generous
support provided by
Olga Mohan, Fred
Simmons and many
others, new approaches Olga Mohan, MD, and
are being pioneered at Fred Simmons
Washington University.
Morris and colleague Randall J. Bateman, MD,
the Charles F. and Joanne Knight Distinguished
Professor of Neurology, have enlisted volunteers
worldwide who have a rare, inherited form of
Alzheimer’s disease that strikes much earlier in life.
As a result, the new study, called the Dominantly
Inherited Alzheimer’s Network Trials Unit
(DIAN-TU), is focused on testing drugs that may
provide a therapeutic benefit at the disease’s earliest stages before symptoms begin. Prevention, the
research suggests, has a better chance of succeeding than treatment after cognitive impairment.
“If the study demonstrates efficacy, it will provide
much needed hope that one day truly effective
therapies for Alzheimer’s will be available,”
Morris said.
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Timothy Ley, MD, left, and Richard Wilson, PhD, and their Washington University colleagues have identified virtually
all of the major mutations driving acute myeloid leukemia.

Continuing the vision
When Joel Siner, MD ’53, names his heroes,
it is a “Who’s Who” of School of Medicine educators and visionaries: Barry Wood Jr., Carl V.
Moore, Neal S. Bricker, Oliver Lowry, Tom Hunter
and many others. These are the individuals who
inspired him as a student and taught him what it
means to be a physician and a scientist.
He continues to find inspiration and take pride
in the physicians and researchers
at Washington University, including when he recently read a New
England Journal of Medicine article
outlining a landmark study on the
acute myeloid leukemia (AML)
genome. Written by members of the
university’s Cancer Genome Atlas
Research Network — including leaders from The Genome Institute —
“We are at a crossroads
the article prompted Siner to make
in cancer genomics.” a significant gift to the institute
for cancer genomic research.
— Timothy Ley, MD
“We will use the gift to support
our new effort to sequence every
new AML patient who comes to the Siteman
Cancer Center,” explained study co-author
and institute director Richard K. Wilson, PhD,
the Alan A. and Edith L. Wolff Distinguished
Professor of Medicine.

Together,
we heal.
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Lead author Timothy
J. Ley, MD, the Lewis T.
and Rosalind B. Apple
Professor of Oncology
and professor of medicine and of genetics,
adds, “We are at a
crossroads in cancer
genomics. Although
much of the work has
Joel Siner, MD
been done to identify
the key mutations that cause many types of cancer,
the next daunting step is how to get this information into the clinic to help patients.
“The early work will have to be supported by
visionary gifts like the one provided by Dr. Siner,
since the major funding agencies need initial proof
that the idea works before they will support the
clinical application of genomics.”
As an internist, Siner was on the staff of Mount
Auburn Hospital, the regional teaching hospital
of Harvard Medical School. He also served as the
hospital’s president and as a member of its board
of Trustees from 1982-87. From 1996-2009, he
served as a member of the internal review board at
Harvard University. Retired from private practice
since May 2000, Siner now lives in Cambridge,
Mass., with his wife, Elinor, a retired psychiatrist.
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As a postdoctoral fellow, Chris Holley, MD, PhD, left, worked alongside Jean Schaffer, MD, the Virginia Minnich Distinguished Professor of Medicine.
Holley now is an instructor of medicine.

The Shawn Hu and Angela Zeng Fellowships support three students for one year. The fellows will
conduct research in the Division of Laboratory and Genomic Medicine. From left: Angela Zeng,
PhD, with the fellowship recipients — Stephen Ferris, Lulu Sun, Benjamin Solomon — and Barry
Sleckman, MD, PhD, the Conan Professor of Laboratory and Genomic Medicine and division director.

ALAN RITTER

Enhance the career of a budding
medical scientist by establishing
an endowed or annual fellowship.
Your fellowship support can benefit
medical scientists in the Medical
Scientist Training Program, the
Division of Biology and Biomedical
Sciences and in academic
departments. Endowed or annual
fellowships may be named
in honor of the donor, a friend,
family member or mentor, or in
memory of a loved one.

Andy Chan with John and Andrea Atkinson
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Fellowship support

RAY MARKLIN

ROBERT BOSTON

Fellows from the School of Medicine have outperformed

and exceeded expectations in their respective fields, leaving an impressive record of success. Fellowship support has
helped many of these outstanding graduate students achieve
their goals and aspirations.
Fellowship programs rely largely on government support,
which has declined significantly. As a result, the door is
open for private philanthropy to have a major impact.
Those who support fellowship programs help to advance
science and make the Washington University experience
affordable for bright students with limited means. Fellowships also are an opportunity to pay tribute to mentors
or loved ones.
Honoring a mentor Campaign committee member Andrew

Chee-Yuen Chan, GM ’86, MD ’86, HS ’89, and his wife
Mary Finnorn Chan, HS ’89, established the John P.
Atkinson Fellowship to honor his mentor. Through the years,
Atkinson, MD, the Samuel B. Grant Professor of Clinical
Medicine and chief of the Division of Rheumatology, has
helped launch the careers of many physician-scientists.
This fellowship, which also has been supported by others,
will be used to recruit the very best pre-doctoral students
to train in human immunology — the focus of Atkinson’s
long and remarkable research career.
“The institution, and most importantly, the people at
the institution have had very positive impacts on my life
and career. I would encourage others to reflect on the
impact this institution has made in their life, and to think
about what they can do to impact future trainees here,”
said Andrew Chan.
Advancing basic science Philip Needleman, GR ’99, emeritus

trustee of Washington University and campaign committee
member, and his wife, Sima, MSW ’74, have established
two annual fellowships.
“We want to attract the most vibrant and promising
pre-doctoral students. To do this, financial support is
needed more than ever,” said Philip Needleman, also former
professor and head of the Department of Pharmacology.
The Philip and Sima K. Needleman Graduate Fellowships
in Regenerative Medicine are under the direction of Lila
Solnica-Krezel, PhD, chair of the Department of Developmental
Biology (formerly the Department of Pharmacology).
“Regenerative medicine is a rapidly progressing discipline
that develops treatments for a wide range of debilitating
human diseases,” said Solnica-Krezel. “The Philip and
Sima K. Needleman Graduate Fellowships will help to attract
the brightest talent into the Developmental, Regenerative
outlook.wustl.edu

& Stem Cell Biology Program and advance regenerative
medicine research at Washington University. With these
fellowships, I am also particularly excited about continuing
the tradition of scientific excellence established during
Dr. Needleman’s tenure as the department chair.”
Helping the next generation Research scholarships made
it possible for Shawn Hu, MD, and his wife, Angela Zeng,
PhD, MBA ’05, to come to the U.S. and pursue careers.
The couple wants to help others by creating medical
research opportunities.
The Shawn Hu and Angela Zeng Fellowships will support
three students for one year, helping to restore critical training needs.
“Although our graduate program support
grant from the National
Institutes of Health
received the highest possible score, we still lost three
training slots because of
“I would encourage
general government budothers to reflect on the
get cuts,” explained Barry
impact
this institution has
Sleckman, MD, PhD,
made in their life ... .”
the Conan Professor of
Laboratory and Genomic
— ANDREW CHAN
Medicine and chief of the
division.
“We are very excited to see our donation make a positive
impact on people to whom we can relate from our own
experience a couple of decades ago,” said Shawn Hu.
“We have made a long-term commitment to contribute
to the future success of the medical school.”

Together,
we lead.

Showing gratitude The Ron and Hanna Evens Fellowship
supports a postdoctoral fellowship in the Mallinckrodt
Institute of Radiology (MIR).
“Hanna and I want to give back in appreciation for all
that the School of Medicine, MIR and the entire Medical
Campus has meant to us. Fellowships are fundamental
to academic pursuit,” said Ronald G. Evens, MD ’64,
formerly president of Barnes-Jewish Hospital and the
Elizabeth Mallinckrodt Professor, head of the Department
of Radiology and director of the Mallinckrodt Institute
of Radiology.
“Endowments that are for younger, up-and-coming
professionals are especially worthwhile to Washington
University and our constant drive to offer the very best
care and education.”
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advancing health

Together
transforming lives

Thank you to the many alumni and friends
who have supported Leading Together: The
Campaign for Washington University through an

Planned giving benefits include:
n

Significant charitable deductions

n

Capital gain tax benefits

changing impact of the scholarships, professorships,

n

Estate tax benefits

research and clinical care these gifts will fund.

n

Lifetime payments to you and/or loved ones

Planned gifts shape the School of Medicine, from

To learn how you can make a planned gift,
contact the Office of Planned Giving:

estate gift, life income plan or other planned gift.
Countless individuals will benefit from the life-

endowed scholarships, such as the Jackson Johnson
Scholars, to innovative research centers, including

(800) 835-3503 or (314) 935-5373

the Grace Nelson Lacey Glaucoma Research Center.

plannedgiving.wustl.edu

Together, we can change lives!
For information on supporting the School of Medicine
through an outright gift, contact:
Pamela Buell, Associate Vice Chancellor for
Medical Alumni and Development
(314) 935-9698

email: meddev@wustl.edu
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Consult with your legal or tax adviser before making a charitable
gift.
Spring
2014

A world seldom seen
The visual systems of birds and reptiles are
among the most sophisticated of any vertebrate.
Turtles’ eyes, for example, contain oil droplets
(above), which act like tiny lenses that help to
distinguish colors. Joseph Corbo, MD, PhD,
associate professor of pathology and immunology, took this microscopic image of a painted
turtle’s retina — magnified 400 times — and
captured second prize in the 2013 Nikon
Small World Photomicroscopy Contest. Using
a technique called differential interference
contrast microscopy, he reveals the lightsensitive cells of the eye called photoreceptors
that contain these colorful droplets.
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Second-year MD/PhD student Kelly Hill captured this poetic winter scene along her running path in Forest Park.
Washington University Medical Center is just visible above the trees in this photo titled “Our Backyard.”
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